Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
about
Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, ChinaHuman herpesvirus 8--a novel human pathogenIdentification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirusVironome of Kaposi sarcoma associated herpesvirus-inflammatory cytokine syndrome in an AIDS patient reveals co-infection of human herpesvirus 8 and human herpesvirus 6AIdentification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localizationAwareness of Kaposi's sarcoma-associated herpesvirus among men who have sex with menThe 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigenRapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signalingDiagnosis of primary human herpesvirus 6 and 7 infections in febrile infants by polymerase chain reactionThe viral etiology of AIDS-associated malignanciesGene expression profile of AIDS-related Kaposi's sarcomaRisk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control studyHistorical review of the causes of cancerThe conundrum of causality in tumor virology: the cases of KSHV and MCVMolecular Approaches to the Identification of Unculturable Infectious AgentsPrimary Characterization of a Herpesvirus Agent Associated with Kaposi’s SarcomaInterference with the Autophagic Process as a Viral Strategy to Escape from the Immune Control: Lesson from Gamma HerpesvirusesRapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug.Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus.Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcomaNovel Kaposi's sarcoma-associated herpesvirus homolog in baboons.Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes.Indocyanine green and laser light for the treatment of AIDS-associated cutaneous Kaposi's sarcoma.Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda.Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy.Epidemiology and genetic variability of HHV-8/KSHV in Pygmy and Bantu populations in Cameroon.Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsHigh-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populationsPerspective on Kaposi's sarcoma: facts, concepts, and conjectures.Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus.A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirusDistinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesisLong-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.Seroprevalence of human herpesvirus 8 and hepatitis C virus among drug users in Shanghai, China.Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirusOrigin-independent assembly of Kaposi's sarcoma-associated herpesvirus DNA replication compartments in transient cotransfection assays and association with the ORF-K8 protein and cellular PML.DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
P2860
Q21245098-896E2BE8-635C-4580-A70A-46EAADE0D6FFQ24530670-28E16130-3C0F-4EDC-8314-7078442E641CQ24561400-F9E04D53-66C5-49E7-B8EB-33ED47807AF6Q24607716-D15ABC1B-A3DD-4513-A160-859CDA4A61F6Q24648127-3B8D7008-5337-4A90-B3FF-DA52594EE539Q24651220-5C0A4A12-6AFD-4B86-AB20-4AA4E7A603FDQ24672438-50CD3D0C-A2A9-4A7A-805B-D6FEA9E9B77DQ24673299-174EEF91-F842-421E-8E84-E5BDE4F43A4FQ24676261-2C79A43F-1B6D-4973-B257-026FB8E0FA56Q24685892-91DC9892-F0B8-45BB-B664-5061BB0F7A94Q24797857-94A04F88-A2DF-4D51-8699-6976F408BC61Q24804288-9A79F689-C1A7-4E99-8FA8-FA2B95C50CB7Q26767036-5C57D92C-CD71-426B-AB18-B1A6169D2322Q26863112-40A154BF-13FD-4DDD-986F-4E0C748E1160Q27487576-DF2555E9-2BB2-4F6F-BEF9-D93747D7F9EBQ27636336-18C1F416-95AD-4E6E-A340-81DFD2A19CB9Q28080898-8DFDF683-4035-4580-A688-C6AE2217D5A9Q28476740-B431CF16-69E3-47EE-A122-85274433B4C7Q30306907-02899FD6-C901-4A4F-AB06-7071C99B09F6Q30445016-D3A620C1-CEAF-4B15-A074-2364CC0D735CQ30452901-6516622C-BAB9-4488-B4EA-60BD00CC5E13Q31121774-D4F97AE3-15E6-43BA-9B75-1895611F8C38Q32075039-7A1581E5-C0AB-4B79-80F8-7E5A65EB269DQ33401242-F3884323-A382-40B5-9D9E-9435EB7500A4Q33610926-957996BC-F6F1-457D-A742-776E53E30E64Q33618403-2007AB92-AAA7-4B54-8AEA-89CCA9AF7EA4Q33647345-7E74A978-C8C9-4BDE-AE73-2F94C43CDBCFQ33647633-68CAF6A0-F255-4873-96F5-DFF5B51EB16FQ33724002-DBE7F5D5-1FBD-492C-8A20-AFCDD55B698EQ33772234-5673DA4D-EED2-4B90-8015-826B029C926AQ33784966-510052AB-057C-49FF-A976-FA39864D5612Q33786189-72963CA7-D065-4E0E-BA2B-8201C3808EF9Q33793963-9D8E3167-2D09-42EF-B033-02979FB9983EQ33815741-05F463C8-0D7B-4E89-9AC6-6F2F80A97AD1Q33815875-1338B753-06DD-480C-8C26-9E3046C39371Q33817882-120A1EFD-17D0-43DC-9479-EA63F2FDF959Q33820738-D44DBB4B-5D33-4591-94AE-AD576197C7CBQ33825453-321758F7-EDA7-48C4-A7D2-5F91AA6ED0ECQ33836726-B9C4A6A8-3011-4CD5-97EE-57D669ED2B3AQ33844093-67CFCF2F-1E82-4EFF-98EB-E4C799D41582
P2860
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Detection of Kaposi sarcoma as ...... ogression to Kaposi's sarcoma.
@en
type
label
Detection of Kaposi sarcoma as ...... ogression to Kaposi's sarcoma.
@en
prefLabel
Detection of Kaposi sarcoma as ...... ogression to Kaposi's sarcoma.
@en
P2093
P1433
P1476
Detection of Kaposi sarcoma as ...... ogression to Kaposi's sarcoma.
@en
P2093
A S Denton
F E Suggett
M R Howard
M Tenant-Flowers
T Hatzioannou
P304
P356
10.1016/S0140-6736(95)91619-9
P407
P50
P577
1995-09-01T00:00:00Z